HOME >> BIOLOGY >> NEWS
Trapping genes that control flower development

Identifying genes based on patterns of gene expression in specific organs or at specific stages of development is a useful approach to improving our understanding of complex biological processes. Scientists Vivian Irish at Yale University in Connecticut, Rob Martienssen at Cold Spring Harbor Laboratory in New York, and their colleagues used a strategy known as "gene trapping" to identify numerous genes involved in the regulation of flower development in the model plant Arabidopsis thaliana. The research is reported in a paper by Nakayama et al. in the September issue of The Plant Cell. The gene trap technique involves genetic transformation of Arabidopsis plants with a reporter gene whose activity is visualized in a simple assay, leading to the rapid identification of genes that show specific patterns of expression. In this case, the researchers isolated 80 different gene trap Arabidopsis lines identifying genes that show distinct patterns of expression in flower petals and/or stamens (the pollen-bearing organs). The research is one of the first large-scale gene trap studies in the area of flower development, and provides extensive information on many genes likely to have critical roles in this essential stage of plant reproduction. Genes provide the blueprints for proteins that carry out the functions of living cells. In any particular organ or tissue at any particular stage of development, gene activity may be "on" (expressing the messenger RNA transcripts that lead to production of the corresponding protein) or "off" (no expression). Examining gene expression patterns therefore provides information on gene function. Gene trapping is an alternative to methods such as DNA microarray analysis for the detection of differentially expressed genes, and has the advantage of identifying subtle differences in expression patterns within target organs. For example, genes expressed only in stamen tissue during the early stages of pollen development are likely to have
'"/>

Contact: Nancy Eckardt
neckardt@aspb.org
970-495-9918
American Society of Plant Biologists
29-Jul-2005


Page: 1 2 3

Related biology news :

1. Interaction of just 2 genes governs coloration patterns in mice
2. Gene regulation, not just genes, is what sets humans apart
3. Study finds gender differences in renal and other genes contributing to blood pressure
4. New databases put wings on search for bipolar risk genes
5. Research teams uncover risk genes for multiple sclerosis
6. Risk genes for multiple sclerosis uncovered
7. Sour taste make you pucker? It may be in your genes
8. U-M, Israeli scientists report major advance in search for genes associated with colon cancer
9. Rapid evolution of defense genes in plants may produce hybrid incompatibility
10. Alcohol abuse is in the genes
11. St. Jude study shows genes play an unexpected role in their own activation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Trapping genes that control flower development

(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/30/2015)... PMG Research, Benchmark Research, and ... formation of VaxCorps, a network of highly experienced, ... conduct of vaccine trials in healthy adult, elderly, ... successfully conducted over 500 phase I-III vaccine clinical ... influenza as well as a vast array of ...
(Date:3/30/2015)... IRVINE, Calif. , March 30, 2015 /PRNewswire/ ... that its subsidiary corporation, NuGene BioPharma, Inc. has ... board. Dr. Guan is an internationally ... After finishing his college education at Peking University, ... his Ph.D. degree from the University of North ...
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... 30, 2015  Spherix Incorporated (Nasdaq: SPEX ... fostering and monetization of intellectual property, today provided ... 3:13-cv-03494-M and  Spherix v. Uniden , Case No. ... for the Northern District of Texas ... v. Verizon, Case No. 1:14-cv-00721-GBL-TCB, in the ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
Cached News: